XML 23 R9.htm IDEA: XBRL DOCUMENT v3.21.2

Accrued and Other Current Liabilities

9 Months Ended

Sep. 30, 2021

Accounts Payable And Accrued Liabilities Current [Abstract]

Accrued and Other Current Liabilities

3. Accrued and Other Current Liabilities

Accrued and other current liabilities consist of the following (in thousands):

		September 30, 2021				December 31, 2020
Accrued clinical trial and related costs		$	21,762			$	11,119
Accrued leasehold improvements			7,470				19
Accrued salaries and benefits			4,790				5,094
Accrued research and development			3,392				3,082
Accrued legal fees			582				252
Accrued professional fees			223				253
Accrued other liabilities			797				583
Total accrued and other current liabilities		$	39,016			$	20,402

X

- Definition

The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.

+ References

No definition available.

+ Details

Name:	us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration